This story originally appeared on Zacks
joint venture (JV) with Eiffel Investment Group, known as European Solar Energy Development JV, has recently acquired its first batch of solar projects in Europe. With a combined capacity of 200 megawatts (MW), this project takes the JV one step closer to its goal of building 700 MW of solar projects over the span of three yearsin Europe.
This project is expected to strengthen ReneSola’s project development capabilities in European solar market.
Europe Solar Market Outlook
Solar market in the European Union ("EU") has show strong resilience in 2020amidtheCOVID-19 induced turmoil. Impressively, demand for solar power in Europe improved 15% in 2020 compared to 2019 level, thus resulting in the EU member states having cumulatively installed 137.2 gigawatts (GW) of solar power capacity, as stated by a report published by the SolarPower Europe.
Looking ahead, the aforementioned report anticipates solar power installations of 22.4 GW in 2021 in the EU. The region is projected to witness installations of 27.4 GW in 2022 and 30.8-GW in 2023. In 2024, the region can record a capacity addition of nearly 35 GW, thereby taking the overall anticipated capacity addition to 253 GW at the end of 2024.
ReneSola’s Expansion Projects in Europe
To capitalize on the opportunities present in the European Solar market, ReneSola has been undertaking significant expansion projects.The company is committed to accelerating solar projects development in Europe.
For instance, ReneSola, in July, sold 38 MW of solar projects located in Poland to Obton. In the same month, the company clinched a partnership agreement with Emeren to develop ground-mounted solar projects in Italy, with a pipeline of several transactions scheduled for 2021. Per the agreement, ReneSola Power and Emeren have a target of developing 110 MW shovel-ready projects by 2022 across the country.
Without a doubt, such initiatives including the latest project acquisition, are likely to strengthen ReneSola’s footprint in the expanding solar European market.
Other solar companies are also expanding their footprint in the region to bank on the rapidly growing solar market in Europe.
For instance, in July 2021, Canadian Solar CSIQ
signed a 10-year power purchase agreement with Centrica Energy Trading A/S for two solar power projects totaling 12 MWp (megawatt-peak) in Italy. The projects are expected to start construction before the end of 2021.
Earlier in September 2020, Enphase Energy ENPH
entered into strategic partnerships with three solar distribution companies in Belgium and the Netherlands to distribute the Enphase IQ 7 family of microinverters to residential installers, across both these nations.
In the same month, First Solar
advanced Series 6 photovoltaic (PV) solar modules were chosen by JP Energie Environnement (JPee) to power its 59-(MW) DC Labarde solar power plant, the largest urban photovoltaic power plant in France.
In the past one year, shares of ReneSola have gained 168.1% compared with the industry
’s growth of 36.9%.
Image Source: Zacks Investment Research
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Renesola Ltd. (SOL): Free Stock Analysis Report
First Solar, Inc. (FSLR): Free Stock Analysis Report
Canadian Solar Inc. (CSIQ): Free Stock Analysis Report
Enphase Energy, Inc. (ENPH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research